PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
In vitro digested infusions inhibited the growth of HT-29 intestinal cancer cells [PMID:35164271]; aqueous extracts and oenothein B reduced the viability and mitochondrial function of Caco-2 colon cancer cells [PMID:41303794].
Plant extracts decreased HIV-1 release and accelerated apoptosis in HIV-1-infected T cells [PMID:37914356].
Extracts showed activity against Gram-positive (e.g., Staphylococcus aureus, Bacillus cereus) and Gram-negative bacteria, as well as antimycotic effects against Microsporum canis and Trichophyton tonsurans [PMID:37895890].
Evidence summary
PubMed sources
- 1.PMID: 27215200 (2016) — Therapeutic Potential of Polyphenols from Epilobium Angustifolium (Fireweed). · Phytotherapy research : PTR
- 2.PMID: 35164271 (2022) — Biological Activity of an Epilobium angustifolium L. (Fireweed) Infusion after In Vitro Digestion. · Molecules (Basel, Switzerland)
- 3.PMID: 31139510 (2019) — Development of simple sequence repeat markers for Chamerion angustifolium (Onagraceae). · Applications in plant sciences
- 4.PMID: 32102409 (2020) — Effect of Different Durations of Solid-Phase Fermentation for Fireweed (Chamerion angustifolium (L.) Holub) Leaves on the Content of Polyphenols and Antioxidant Activity In Vitro. · Molecules (Basel, Switzerland)
- 5.PMID: 40851018 (2025)